medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2024, Number 08

<< Back

Ginecol Obstet Mex 2024; 92 (08)

Involvement of simple ovarian cysts with combined oral hormones in patients of chilbearing age.

Villa VF, Villa GRA, Bravo RJ, Ballesteros MA, Panduro BJG, Ochoa HM
Full text How to cite this article

Language: Spanish
References: 15
Page: 352-357
PDF size: 196.30 Kb.


Key words:

Simple ovarian cyst, Ethinyl estradiol, Drospirenone, Marital status, age of onset, Pregnancy.

ABSTRACT

Objective: To determine the natural evolution and effects, after two months, of combined oral hormonal drugs indicated for patients of childbearing age with simple ovarian cysts and their difference with a control group.
Materials and Methods: Prospective, longitudinal, descriptive, comparative and experimental study conducted in the Gynecobstetrics Service of the Civil Hospital of Guadalajara Fray Antonio Alcalde in patients attended between April 2018 and March 2019 with a diagnosis of simple ovarian cyst. Patients were randomized to two study groups: those treated with ethinyl estradiol and drospirenone (group A) and those who received only placebo (group B). The groups were similar with respect to age, marital status, occupation, pregnancies, and history of ovarian cysts.
Results: Two groups of 40 patients each were studied. After two months of treatment, regression occurred in 32 cases in group A and in 22 cases in group B, with a significant difference. None of the cysts larger than 65 mm regressed.
Conclusion: The most common age of onset of simple ovarian cysts is between 20 and 29 years. Of the sample studied, regression was observed in 32 of 40 patients treated, but not in ovarian cysts larger than 65 mm. The prescription of combined oral contraceptives is recommended in the treatment of patients with simple ovarian cysts between 30 and 65 mm to increase their regression rate and thus avoid surgery.


REFERENCES

  1. Grimes DA, Jones LB, Lopez LM, Schulz KF. Oral contraceptivesfor functional ovarian cysts. CochraneDatabase Syst Rev 2014; 29 (4): CD006134. https://doi.org/10.1002/14651858.CD006134.pub5

  2. González VM, Goity FC, Kahn ChM. ¿Son útiles los anticonceptivosorales en el tratamiento de los quistes ováricosfuncionales? Rev Chilena Obstet Ginecol 2007; 72 (6): 402-406. https://doi.org/10.4067/s0717-75262007000600008

  3. Naz T, Akhter Z, Jamal T. Oral contraceptives versus expectanttreatment in the management of functional ovarian cysts. JMed Sci 2011; 19 (4): 185-188. https://jeffreydachmd.com/wp-content/uploads/2016/06/ORAL-Contraceptives-Vs-EXPECTANT-TREATMENT-Ovarian-Cysts-Talat-Naz-2011.pdf

  4. Sarkar M, Wolf MG. Simple ovarian cysts in postmenopausalwomen: scope of conservative management. Eur JObstet Gynecol Reprod Biol 2012; 162: 75-78. https://doi.org/10.1016/j.ejogrb.2011.12.034

  5. Mobeen S, Apostol R. Ovarian Cyst. [Updated 2023 Jun 5].In: StatPearls [Internet]. Treasure Island (FL): StatPearlsPublishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560541/

  6. Ross EK, Kebria M. Incidental ovarian cysts: When to reassure,when to reassess, when to refer. Cleveland Clinic J Med 2013;80 (8): 503-514. https://doi.org/10.3949/ccjm.80a.12155

  7. ACOG Practice Bulletin No. 174. Evaluation and managementof adnexal. Obstet Gynecol 2016; 128 (5): e210-e226.https://doi.org/10.1097/aog.0000000000001768

  8. Vásquez-Awad D. Beneficios de los anticonceptivos oralescombinados. Ginecol Obstet Mex 2020; 88 (Supl 1): S47-S55. https://doi.org/10.24245/gom.v88iSupl1.3849

  9. Vásquez-Awad D, Ospino AM. Anticonceptivos orales combinados.Ginecol Obstet Mex. 2020; 88 (Supl 1): S13-S31.https://doi.org/10.24245/gom.v88iSupl1.3843

  10. Schindler AE. Non-Contraceptive benefits of oral hormonalcontraceptives. Int J Endocrinol Metab 2013; 11 (1): 41-7.https://doi.org/10.5812/ijem.4158

  11. Seehusen DA, Earwood JS. Oral contraceptives are notan effective treatment for ovarian cysts. Am Fam Physician2014; 90 (9): 623. Cochrane https://www.aafp.org/pubs/afp/issues/2014/1101/p623.pdf

  12. MacKenna A, Fabres C, Alam V, Morales V. Clinical managementof functional ovarian cysts: a prospective andrandomized study. Hum Reprod 2000; 15 (12): 2567-9.https://doi.org/10.1093/humrep/15.12.2567

  13. Christensen JT, Boldsen JL, Westergaard JG. Functionalovarian cysts in premenopausal and gynecologicallyhealthy women. Contraception 2002; 66 (3): 153-57.https://doi.org/10.1016/s0010-7824(02)00353-0

  14. Bayar U, Barut A, Ayoğlu F. Diagnosis and management ofsimple ovarian cysts. Int J Gynaecol Obstet 2005; 91(2):187-8. https://doi.org/10.1016/j.ijgo.2005.07.021

  15. Knudsen UB, Tabor A, Mosgaard B, Andersen ES, et al.Management of ovarian cysts. Acta Obstet Gynecol Scand2004; 83 (11): 1012-21. https://doi.org/10.1111/j.0001-6349.2004.00607.x




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2024;92